Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Liquidia Corp (NQ: LQDA )

8.890 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 600
Open 8.890
Bid (Size) 8.700 (1)
Ask (Size) 8.910 (1)
Prev. Close 8.890
Today's Range 8.890 - 8.890
52wk Range 3.380 - 8.900
Shares Outstanding 64,717,549
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Liquidia Corporation to Present at the 2023 Jefferies Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
Hero or Zero? 7 High-Risk Stocks to Make You Rich… Or Broke.
These seven high-risk stocks could ultimately rocket to the moon, or fall to the depths of the stock market graveyard. 
Via InvestorPlace

Performance

YTD
+45.98%
+45.98%
1 Month
+20.14%
+20.14%
3 Month
+21.78%
+21.78%
6 Month
+71.62%
+71.62%
1 Year
+121.14%
+121.14%

More News

Read More
Liquidia Announces Poster Presentation at the 2023 American Thoracic Society International Conference
From Liquidia Corporation
Via GlobeNewswire
Liquidia: Q1 Earnings Insights
Via Benzinga
Liquidia Corporation Reports First Quarter 2023 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Earnings Outlook For Liquidia
Via Benzinga
Where Liquidia Stands With Analysts
Via Benzinga
Liquidia Corporation to Present at BofA Securities 2023 Health Care Conference
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Report First Quarter 2023 Financial Results on May 4, 2023
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Present at 22nd Annual Needham Virtual Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
Liquidia and GSK Restructure License to PRINT Technology for Inhaled Applications
From Liquidia Corporation
Via GlobeNewswire
Needham Maintains Buy Rating for Liquidia: Here's What You Need To Know
Via Benzinga
Liquidia Technologies's Earnings: A Preview
Via Benzinga
NVIDIA To Rally Around 19%? Here Are 10 Other Analyst Forecasts For Friday
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Liquidia Corporation Reports Full Year 2022 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Report Full Year 2022 Financial Results on Thursday, March 16, 2023
From Liquidia Corporation
Via GlobeNewswire
Patent Trial and Appeal Board (PTAB) Reaffirms Decision to Invalidate All Claims of United Therapeutics (UTHR) Patent No. 10,716,793 (‘793 Patent)
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Liquidia Corporation
Via GlobeNewswire
Liquidia Enters Into a Revenue Interest Financing Agreement With HealthCare Royalty for Up to $100 Million
From Liquidia Corporation
Via GlobeNewswire
Liquidia Announces Collaboration to Develop a New Infusion Pump for Subcutaneous Delivery of Treprostinil Injection to Treat Pulmonary Arterial Hypertension (PAH)
From Liquidia Corporation
Via GlobeNewswire
Liquidia Reports Third Quarter 2022 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Earnings Outlook For Liquidia Technologies
Via Benzinga
Liquidia to Report Third Quarter 2022 Financial Results on November 8, 2022
From Liquidia Corporation
Via GlobeNewswire
Precedential Opinion Panel Denies United Therapeutics’ Request for Review of ‘793 Inter Partes Review Decision
From Liquidia Corporation
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.